Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026)
Stoke Therapeutics (STOK) recorded quarterly Prepaid Assets of $10.1 million in Q1 2026, up 130.46% quarter-over-quarter from $4.4 million in Q4 2025, and down 20.32% on a YoY basis from $12.7 million in Q1 2025.
Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026) Analysis & Trends
Stoke Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $10.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 20.32% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $10.1 million (down 20.32% YoY), while the FY2025 annual figure was $4.4 million, up 91.08% from the prior year.
- Prepaid Assets was $10.1 million for Q1 2026 at Stoke Therapeutics, up from $4.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.2 million in Q2 2022 to a low of $2.3 million in Q4 2024.
- Historically, Prepaid Assets has averaged $7.8 million across 5 years, with a median of $7.7 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 71.93% in 2023, then soared 91.08% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $3.0 million in 2022, then fell by 13.33% to $2.6 million in 2023, then dropped by 10.31% to $2.3 million in 2024, then jumped by 91.08% to $4.4 million in 2025, then jumped by 130.46% to $10.1 million in 2026.
- The last three Prepaid Assets figures came in at $10.1 million (Q1 2026), $4.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.12 Mn |
| Dec 31, 2025 | 4.39 Mn |
| Sep 30, 2025 | 7.75 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Mar 31, 2025 | 12.69 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 10.94 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | 12.55 Mn |
| Jun 30, 2022 | 13.18 Mn |
| Mar 31, 2022 | 12.29 Mn |
| Dec 31, 2021 | 2.22 Mn |
| Sep 30, 2021 | 8.47 Mn |
| Jun 30, 2021 | 8.61 Mn |